EUS-FNB With ROSE Vs. EUS-FNB Without ROSE

NACompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

March 29, 2018

Primary Completion Date

December 13, 2019

Study Completion Date

July 30, 2020

Conditions
Biopsy, Fine-needlePancreatic Neoplasm
Interventions
DIAGNOSTIC_TEST

Rapid on-site evaluation (ROSE)

On-site evaluation of the acquired samples will be performed by pathologist

DIAGNOSTIC_TEST

Histologic evaluation

Samples collected in the EUS-FNB without ROSE will be processed as histologic samples

Trial Locations (13)

22901

University of Virginia Health Sciences Center, Charlottesville

37134

Azienda Ospedaliera Integrata Verona, Verona

Unknown

Royal Adelaide Hospital, Adelaide

Cliniques Universitaires St-Luc, Brussels

Istituto Humanitas, Milan

ISMETT, Palermo

Ospedale Civico, Palermo

Tokyo Medical University Hospital, Tokyo

Wakayama Medical University School of Medicine, Wakayama

Erasmus MC, Rotterdam

Hospital Clinic, Barcelona

Hospital Clinico Univarsitario de Santiago, Santiago de Compostela

Karolinska Institutet, Stockholm

All Listed Sponsors
lead

Azienda Ospedaliera Universitaria Integrata Verona

OTHER

NCT03322592 - EUS-FNB With ROSE Vs. EUS-FNB Without ROSE | Biotech Hunter | Biotech Hunter